Annual D&A
$183.90 K
+$14.90 K+8.82%
31 December 2023
Summary:
Cardiol Therapeutics annual depreciation & amortization is currently $183.90 thousand, with the most recent change of +$14.90 thousand (+8.82%) on 31 December 2023. During the last 3 years, it has risen by +$12.60 thousand (+7.36%). CRDL annual D&A is now at all-time high.CRDL Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$147.60 K
+$103.00 K+230.94%
30 September 2024
Summary:
Cardiol Therapeutics quarterly depreciation & amortization is currently $147.60 thousand, with the most recent change of +$103.00 thousand (+230.94%) on 30 September 2024. Over the past year, it has increased by +$99.00 thousand (+203.70%). CRDL quarterly D&A is now at all-time high.CRDL Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$286.50 K
+$99.00 K+52.80%
30 September 2024
Summary:
Cardiol Therapeutics TTM depreciation & amortization is currently $286.50 thousand, with the most recent change of +$99.00 thousand (+52.80%) on 30 September 2024. Over the past year, it has increased by +$106.10 thousand (+58.81%). CRDL TTM D&A is now at all-time high.CRDL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDL Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.8% | +203.7% | +58.8% |
| 3 y3 years | +7.4% | +252.3% | +64.8% |
| 5 y5 years | +160.5% | +383.9% | +202.8% |
CRDL Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +8.8% | at high | +269.9% | at high | +69.7% |
| 5 y | 5 years | at high | +160.5% | at high | +383.9% | at high | +202.8% |
| alltime | all time | at high | +346.4% | at high | +768.2% | at high | +1509.5% |
Cardiol Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $147.60 K(+230.9%) | $286.50 K(+52.8%) |
| June 2024 | - | $44.60 K(-2.4%) | $187.50 K(+0.5%) |
| Mar 2024 | - | $45.70 K(-6.0%) | $186.60 K(+1.5%) |
| Dec 2023 | $183.90 K(+8.8%) | $48.60 K(0.0%) | $183.90 K(+1.9%) |
| Sept 2023 | - | $48.60 K(+11.2%) | $180.40 K(+5.1%) |
| June 2023 | - | $43.70 K(+1.6%) | $171.70 K(+1.2%) |
| Mar 2023 | - | $43.00 K(-4.7%) | $169.70 K(+0.4%) |
| Dec 2022 | $169.00 K(-3.9%) | $45.10 K(+13.0%) | $169.00 K(+0.1%) |
| Sept 2022 | - | $39.90 K(-4.3%) | $168.80 K(-1.2%) |
| June 2022 | - | $41.70 K(-1.4%) | $170.80 K(-2.4%) |
| Mar 2022 | - | $42.30 K(-5.8%) | $175.00 K(-0.5%) |
| Dec 2021 | $175.80 K | - | - |
| Dec 2021 | - | $44.90 K(+7.2%) | $175.80 K(+1.2%) |
| Sept 2021 | - | $41.90 K(-8.7%) | $173.80 K(-2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $45.90 K(+6.5%) | $178.20 K(+3.4%) |
| Mar 2021 | - | $43.10 K(+0.5%) | $172.40 K(+0.6%) |
| Dec 2020 | $171.30 K(+51.1%) | $42.90 K(-7.3%) | $171.30 K(+3.3%) |
| Sept 2020 | - | $46.30 K(+15.5%) | $165.80 K(+10.5%) |
| June 2020 | - | $40.10 K(-4.5%) | $150.00 K(+8.9%) |
| Mar 2020 | - | $42.00 K(+12.3%) | $137.80 K(+21.5%) |
| Dec 2019 | $113.40 K(+60.6%) | $37.40 K(+22.6%) | $113.40 K(+19.9%) |
| Sept 2019 | - | $30.50 K(+9.3%) | $94.60 K(+16.4%) |
| June 2019 | - | $27.90 K(+58.5%) | $81.30 K(+15.5%) |
| Mar 2019 | - | $17.60 K(-5.4%) | $70.40 K(-0.3%) |
| Dec 2018 | $70.60 K(+71.4%) | $18.60 K(+8.1%) | $70.60 K(+35.8%) |
| Sept 2018 | - | $17.20 K(+1.2%) | $52.00 K(+49.4%) |
| June 2018 | - | $17.00 K(-4.5%) | $34.80 K(+95.5%) |
| Mar 2018 | - | $17.80 K | $17.80 K |
| Dec 2017 | $41.20 K | - | - |
FAQ
- What is Cardiol Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Cardiol Therapeutics?
- What is Cardiol Therapeutics annual D&A year-on-year change?
- What is Cardiol Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Cardiol Therapeutics?
- What is Cardiol Therapeutics quarterly D&A year-on-year change?
- What is Cardiol Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Cardiol Therapeutics?
- What is Cardiol Therapeutics TTM D&A year-on-year change?
What is Cardiol Therapeutics annual depreciation & amortization?
The current annual D&A of CRDL is $183.90 K
What is the all time high annual D&A for Cardiol Therapeutics?
Cardiol Therapeutics all-time high annual depreciation & amortization is $183.90 K
What is Cardiol Therapeutics annual D&A year-on-year change?
Over the past year, CRDL annual depreciation & amortization has changed by +$14.90 K (+8.82%)
What is Cardiol Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of CRDL is $147.60 K
What is the all time high quarterly D&A for Cardiol Therapeutics?
Cardiol Therapeutics all-time high quarterly depreciation & amortization is $147.60 K
What is Cardiol Therapeutics quarterly D&A year-on-year change?
Over the past year, CRDL quarterly depreciation & amortization has changed by +$99.00 K (+203.70%)
What is Cardiol Therapeutics TTM depreciation & amortization?
The current TTM D&A of CRDL is $286.50 K
What is the all time high TTM D&A for Cardiol Therapeutics?
Cardiol Therapeutics all-time high TTM depreciation & amortization is $286.50 K
What is Cardiol Therapeutics TTM D&A year-on-year change?
Over the past year, CRDL TTM depreciation & amortization has changed by +$106.10 K (+58.81%)